Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 30, 2016
SEOM Clinical Guideline for bone metastases from solid tumours (2016)C Grávalos, C Rodríguez, A Sabino, et al.
Actas Dermo-Sifiliograficas|April 24, 2019
Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical OncologyO Sanmartín, C Beato, H Jin Suh-Oh, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical OncologyC Grávalos, O Sanmartín, A Gúrpide, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2015
Seom guidelines for the treatment of gastric cancer 2015M Martin-Richard, A Custodio, C García-Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 17, 2014
Clinical management of regorafenib in the treatment of patients with advanced colorectal cancerJ Sastre, G Argilés, M Benavides, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2017
SEOM clinical guideline for treatment of cancer pain (2017)C Jara, S Del Barco, C Grávalos, et al.
Critical Reviews in Oncology/Hematology|January 1, 2010
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)J Sastre, E Aranda, C Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 23, 2008
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancerA Jimeno, C Grávalos, P Escudero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 15, 2014
TTD consensus document on the diagnosis and management of exocrine pancreatic cancerM Benavides, A Abad, I Ales, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2011
Recommendations and expert opinion on the treatment of locally advanced rectal cancer in SpainC Grávalos, P García-Alfonso, R Afonso, et al.
Pageof 3